Seres Therapeutics (MCRB) Treasury Shares (2014 - 2026)
Seres Therapeutics (MCRB) posted Treasury Shares of $185120.0 for Q1 2026, up 666.54% sequentially from $24150.0 in Q4 2025, and up 142.06% YoY from $76477.0 in Q1 2025.
Seres Therapeutics (MCRB) Treasury Shares (2014 - 2026) Analysis & Trends
Seres Therapeutics has reported Treasury Shares for 13 years, with the latest figure at $185120.0 in Q1 2026.
- Quarterly Treasury Shares rose 142.06% year-over-year to $185120.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $185120.0 (up 142.06% YoY) and the FY2025 annual result came in at $24150.0, down 70.35% from the prior year.
- Treasury Shares advanced to $185120.0 in Q1 2026 per MCRB's latest filing, from $24150.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $4.2 million in Q1 2023 and troughed at $24150.0 in Q4 2025.
- A 5-year average of $1.9 million and a median of $1.6 million in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares surged 449.81% in 2022, then slumped 98.66% in 2025.
- Over 5 years, Treasury Shares stood at $1.5 million in 2022, then soared by 117.99% to $3.4 million in 2023, then plunged by 97.59% to $81459.0 in 2024, then slumped by 70.35% to $24150.0 in 2025, then surged by 666.54% to $185120.0 in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $185120.0, $24150.0, and $100824.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Seres Therapeutics | 43.87 Mn | 43.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 161,748.00 |
| Jun 30, 2026 | 161,748.00 |
| Mar 31, 2026 | 185,120.00 |
| Mar 31, 2026 | 185,120.00 |
| Dec 31, 2025 | 24,150.00 |
| Dec 31, 2025 | 24,150.00 |
| Sep 30, 2025 | 100,824.00 |
| Sep 30, 2025 | 100,824.00 |
| Jun 30, 2025 | 51,199.00 |
| Jun 30, 2025 | 51,199.00 |
| Mar 31, 2025 | 76,477.00 |
| Mar 31, 2025 | 76,477.00 |
| Dec 31, 2024 | 81,459.00 |
| Dec 31, 2024 | 81,459.00 |
| Sep 30, 2024 | 2.75 Mn |
| Sep 30, 2024 | 2.75 Mn |
| Jun 30, 2024 | 3.81 Mn |
| Jun 30, 2024 | 3.81 Mn |
| Mar 31, 2024 | 4.15 Mn |
| Mar 31, 2024 | 4.15 Mn |